Resultados de procura - Rudolf A. de Boer

Limitar resultados
  1. 1
    Management of cardiac fibrosis is the largest unmet medical need in heart failure

    Management of cardiac fibrosis is the largest unmet medical need in heart failure por Javier Dı́ez, Rudolf A. de Boer

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Common risk factors for heart failure and cancer

    Common risk factors for heart failure and cancer por Wouter C. Meijers, Rudolf A. de Boer

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects

    Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects por Anne E. de Leeuw, Rudolf A. de Boer

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

    Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer por Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Galectin-3 in Cardiac Remodeling and Heart Failure

    Galectin-3 in Cardiac Remodeling and Heart Failure por Rudolf A. de Boer, Lili Yu, Dirk J. van Veldhuisen

    Publicado 2010
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    The fibrosis-cell death axis in heart failure

    The fibrosis-cell death axis in heart failure por Arnold Piek, Rudolf A. de Boer, Herman H.W. Silljé

    Publicado 2016
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

    Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease por Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Emerging role of liver X receptors in cardiac pathophysiology and heart failure

    Emerging role of liver X receptors in cardiac pathophysiology and heart failure por Megan V. Cannon, Wiek H. van Gilst, Rudolf A. de Boer

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Galectin-3 in Heart Failure

    Galectin-3 in Heart Failure por Carolin Gehlken, Navin Suthahar, Wouter C. Meijers, Rudolf A. de Boer

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Current understanding of fibrosis in genetic cardiomyopathies

    Current understanding of fibrosis in genetic cardiomyopathies por Tim R. Eijgenraam, Herman H.W. Silljé, Rudolf A. de Boer

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    State of the Art: Newer biomarkers in heart failure

    State of the Art: Newer biomarkers in heart failure por Rudolf A. de Boer, Lori B. Daniels, Alan S. Maisel, James L. Januzzi

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Biomarkers in heart failure with preserved ejection fraction

    Biomarkers in heart failure with preserved ejection fraction por Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    Novel heart failure biomarkers: why do we fail to exploit their potential?

    Novel heart failure biomarkers: why do we fail to exploit their potential? por Arnold Piek, Weijie Du, Rudolf A. de Boer, Herman H.W. Silljé

    Publicado 2018
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

    Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies por Sanne de Wit, Claire Glen, Rudolf A. de Boer, Ninian N. Lang

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

    From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities por Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Telemedicine in heart failure—more than nice to have?

    Telemedicine in heart failure—more than nice to have? por Casper Eurlings, Josiane Boyne, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Sex‐related differences in contemporary biomarkers for heart failure: a review

    Sex‐related differences in contemporary biomarkers for heart failure: a review por Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, Rudolf A. de Boer

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis

    Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis por Graeme J. Koelwyn, Joseph Pierre Aboumsallem, Kathryn J. Moore, Rudolf A. de Boer

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  19. 19
    Telomere biology in healthy aging and disease

    Telomere biology in healthy aging and disease por Hisko Oeseburg, Rudolf A. de Boer, Wiek H. van Gilst, Pim van der Harst

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin <i>vs</i> placebo or empagliflozin in patients with type 2 diabetes and heart failure

    Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin <i>vs</i> placebo or empagliflozin in patients with type 2 diabetes and heart failure por Rudolf A. de Boer, Julio Núñez, Plamen Kozlovski, Yi Wang, Pieter Proot, Deborah Keefe

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: